Predicting chemo response with exosomes in breast cancer
Part of Cancer, Skin clinical trials.
This trial looks at tiny particles called exosomes from your blood and leftover tumor tissue to see if they can predict how well chemotherapy works before surgery. The goal is to find markers that help doctors choose the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have locally advanced breast cancer and are scheduled to get chemotherapy before surgery.
- You have leftover tumor tissue and/or blood samples available from your routine care.
- You can give written consent to participate.
- You have not had chemotherapy or radiation for this breast cancer before joining the trial.
- You do not have breast cancer that has spread to distant parts of your body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying tiny molecules in your blood (called microRNAs) to see if they can predict how well breast cancer responds to chemotherapy given before surgery. If you are starting neoadjuvant chemotherapy, this study may help personalize your treatment.
This study looks at how well a computer model can predict if breast cancer will completely respond to chemotherapy before surgery. It is for people with early-stage breast cancer who are about to start neoadjuvant chemotherapy.
This trial studies small particles in the blood (called extracellular vesicles) in people receiving chemotherapy before surgery for breast cancer. It may help doctors learn more about what those particles can tell them during neoadjuvant treatment.
This study checks whether a blood test that looks for “tumor DNA” (circulating tumor DNA) can help evaluate how well neoadjuvant chemotherapy worked for breast cancer. It may help doctors better understand treatment response after surgery.
This study looks at tiny particles released by cells (called extracellular vesicles) in people with breast cancer. It may help researchers better understand breast cancer and how it behaves, which could improve future testing or treatments.
This study grows mini versions of your breast cancer tumor in the lab to understand why some cancers resist chemotherapy. Researchers use this information to help predict which treatment might work best for you.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.